Scalper1 News
News from the Medicines Company (MDCO) Monday was a reminder that innovation is alive and well in the biotech space. Shares surged after the company announced positive phase-one trial data for an experimental cholesterol drug it’s developing with Alnylam Pharmaceuticals (ALNY). IBD’s Medical-Biomed/Biotech group has slipped a bit in IBD’s 197 industry group rankings, but it’s still holding its own in the top 20. Headed into Monday, it ranked No. Scalper1 News
Scalper1 News